Elestrin™ is a new gel formulation of estradiol that benefits from the technological advantages of transdermal administration. By virtue of its sustained release, Elestrin may be applied once daily.

Transdermal estradiol patches may be an alternative to LHRHas when combined with ARPIs to treat mHSPC, researchers say.

Investigators report that estradiol works as well as luteinizing hormone–releasing hormone agonists for testosterone suppression and have a much better side-effect profile.

Hall scheduled an appointment with a specialist, and in 2024 started testosterone replacement therapy (TRT)—receiving regular ...

After hours: February 20 at 6:40:00 PM EST ...

Dec. 11, 2024 at 4:48 p.m. ET on TipRanks.com ...

Transdermal estradiol was shown to be as effective as LHRH agonists, with similar metastasis-free survival (86% vs. 87%) and overall survival. Additionally, transdermal estradiol improved bone mineral ...